TickerFacts.

Bioventus Inc. (BVS): EPS (Diluted)

Annual figures by period end, from SEC filings.

$0.33
Year ended 2025-12-31
2021-12-31: -$0.152022-12-31: -$2.592023-12-31: -$2.492024-12-31: -$0.562025-12-31: $0.33$0.33
2021-12-31 EPS (Diluted) (USD per share) 2025-12-31
Period endedEPS (Diluted)Change YoYSource filing
2025-12-31$0.33n/m2026-03-05, From 2025-01-01
2024-12-31-$0.56n/m2026-03-05, From 2024-01-01
2023-12-31-$2.49n/m2026-03-05, From 2023-01-01
2022-12-31-$2.59n/m2025-03-11, From 2022-01-01
2021-12-31-$0.15n/a2024-03-12, From 2021-01-01

EPS (Diluted) at similar companies

Companies with the same SEC industry code (Surgical & Medical Instruments & Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedEPS (Diluted)Change YoY
Bioventus Inc. (BVS)2025-12-31$0.33n/m
UFP Technologies Inc (UFPT)2025-12-31$8.75+15.4%
AtriCure, Inc. (ATRC)2025-12-31-$0.24n/m
Glaukos Corp (GKOS)2025-12-31-$3.28n/m
NovoCure Ltd (NVCR)2025-12-31-$1.22n/m
Artivion, Inc. (AORT)2025-12-31$0.21n/m
iRhythm Holdings, Inc. (IRTC)2025-12-31-$1.39n/m
Alphatec Holdings, Inc. (ATEC)2025-12-31-$0.96n/m
Mimedx Group, Inc. (MDXG)2025-12-31$0.32+14.3%

Compare BVS, UFPT, ATRC, GKOS side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗